Literature DB >> 7446549

The liver in sickle cell disease. A clinicopathologic study of 70 patients.

T W Bauer, G W Moore, G M Hutchins.   

Abstract

In clinical studies, frequent hepatic dysfunction associated with crises in sickle cell disease has been noted, but whether irreversible morphologic changes arise from these transient episodes is uncertain. We studied 70 patients with sickle cell disease (57 SS, 12 SC and one S-thalassemia (S-thal) hemoglobin) autopsied at The Johns Hopkins Hospital. They ranged in age from five months to 75 years (average 21 years) and 35 (50 percent) were female, In 64 patients (91 percent), livers were enlarged and had distention of Kupffer cells with phagocytized sickled red cells; this was massive in 10. In 19 patients (27 percent) the sinusoids were markedly distended with sickled red cells and appeared obstructed. Focal parenchymal necroses were present in 24 patients (34 percent) and were explained in 12, eight by cardiac dysfunction and four by sepsis. Reparative changes, portal fibrosis and regenerative nodules were each found in 14 patients (20 percent), only one of whom had a known history of viral hepatitis despite the frequency of transfusions. Cirrhosis of unknown cause was present in seven patients and cardiac cirrhosis in one. Cirrhosis with hemochromatosis was present in three patients and 30 others had parenchymal iron accumulation. Thus, unexplained hepatic necroses, portal fibrosis, regenerative nodules and cirrhosis were frequently encountered in these patients. This spectrum of liver disease appears to be best understood as a consequence of recurrent vascular obstruction, necrosis and repair arising as a component of sickle cell disease.

Entities:  

Mesh:

Year:  1980        PMID: 7446549     DOI: 10.1016/s0002-9343(80)80008-8

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  32 in total

1.  [Pathology along the liver sinusoids: intrasinusoidal findings].

Authors:  U Flucke; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

2.  Microfluidic study of enhanced deposition of sickle cells at acute corners.

Authors:  Etienne Loiseau; Gladys Massiera; Simon Mendez; Patricia Aguilar Martinez; Manouk Abkarian
Journal:  Biophys J       Date:  2015-06-02       Impact factor: 4.033

3.  Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient.

Authors:  Daniel B Costa; Rebecca A Miksad; Michael S Buff; Yihong Wang; Bruce J Dezube
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

4.  Excessive binding of natural anti-alpha-galactosyl immunoglobin G to sickle erythrocytes may contribute to extravascular cell destruction.

Authors:  U Galili; M R Clark; S B Shohet
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

5.  Studies of the kallikrein-kinin system in patients with sickle cell anemia.

Authors:  R L Miller; P S Verma; R G Adams
Journal:  J Natl Med Assoc       Date:  1983-06       Impact factor: 1.798

6.  Acute hepatic sequestration in sickle cell disease.

Authors:  William E Norris
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

7.  Liver Cirrhosis in a Patient with Sickle Cell Trait (Hb Sβ Thalassemia) without Other Known Causes of Hepatic Disease.

Authors:  Luca Santi; Giancarlo Montanari; Sonia Berardi; Corrado Patti; Marta Frigerio; Claudia Sama; Paolo Caraceni; Mauro Bernardi
Journal:  Case Rep Gastroenterol       Date:  2009-09-12

8.  Spontaneous fistulisation and drainage of a pyogenic liver abscess into the stomach in an adult patient with sickle cell disease.

Authors:  Shariful Islam; Devin Hosein; Vinoo Bheem; Patrick Harnarayan
Journal:  BMJ Case Rep       Date:  2016-03-14

Review 9.  Acute liver function decompensation in a patient with sickle cell disease managed with exchange transfusion and endoscopic retrograde cholangiography.

Authors:  Haris Papafragkakis; Mel A Ona; Kinesh Changela; Swayamprabha Sadanandan; Abraham Jelin; Sury Anand; Sushil Duddempudi
Journal:  Therap Adv Gastroenterol       Date:  2014-09       Impact factor: 4.409

10.  Adverse effects of a clinically relevant dose of hydroxyurea used for the treatment of sickle cell disease on male fertility endpoints.

Authors:  Kea M Jones; Mohammad S Niaz; Cynthia M Brooks; Shannon I Roberson; Maria P Aguinaga; Edward R Hills; Valerie Montgomery Rice; Phillip Bourne; Donald Bruce; Anthony E Archibong
Journal:  Int J Environ Res Public Health       Date:  2009-03-16       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.